Wright J M, Price S D, Watson W A
Department of Medicine, School of Medicine, University of Missouri-Kansas City.
Ann Pharmacother. 1994 Mar;28(3):309-12. doi: 10.1177/106002809402800301.
To compare the clinical efficacy of single doses of intramuscular ketorolac and oral ibuprofen in the emergency department (ED) treatment of acute pain.
A retrospective analysis of data collected during a prospective survey of pain management efficacy. The design was noninterventional, and therapy was selected by the treating physician independent of the trial.
Urban teaching hospital adult patient emergency department.
A convenience sample of ED patients in acute pain.
Patients received ibuprofen 800 mg po (n = 95), or ketorolac 60 mg im (n = 30) as a single dose. Therapy was selected by the treating physician and was not influenced by the study.
Data collected were a 100-mm visual analog pain scale at patient arrival and discharge, verbal description of pain relief, patient demographics, pain management data, and discharge diagnosis. Baseline pain intensity was higher in patients receiving ketorolac (77 mm median) than in those receiving ibuprofen (65 mm, p = 0.02). Pain relief was similar (p = 0.29) with either treatment when assessed by visual analog scale or patient definition of pain relief.
A single dose of either nonsteroidal antiinflammatory drug produced similar pain relief in the general ED population during clinical treatment of pain. Ketorolac should not necessarily be considered a more effective analgesic than ibuprofen in these commonly used doses.
比较单剂量肌内注射酮咯酸和口服布洛芬在急诊科治疗急性疼痛的临床疗效。
对前瞻性疼痛管理疗效调查期间收集的数据进行回顾性分析。该设计为非干预性,治疗由主治医生独立于试验选择。
城市教学医院成人急诊科。
急性疼痛的急诊科患者便利样本。
患者接受单剂量口服布洛芬800mg(n = 95)或肌内注射酮咯酸60mg(n = 30)。治疗由主治医生选择,不受研究影响。
收集的数据包括患者就诊时和出院时的100mm视觉模拟疼痛量表、疼痛缓解的口头描述、患者人口统计学资料、疼痛管理数据和出院诊断。接受酮咯酸治疗的患者基线疼痛强度(中位数77mm)高于接受布洛芬治疗的患者(65mm,p = 0.02)。通过视觉模拟量表或患者对疼痛缓解的定义评估,两种治疗的疼痛缓解情况相似(p = 0.29)。
在疼痛的临床治疗中,单剂量的任何一种非甾体抗炎药在普通急诊科患者中产生的疼痛缓解效果相似。在这些常用剂量下,酮咯酸不一定被认为比布洛芬更有效。